-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905. Outcomes Research—Lymphoid Malignancies: Poster II

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Ryan Jacobs, MD1*, Ruibin Wang, PhD2*, Jinghua He, PhD2*, Xiaoxiao Lu, PhD, MD, MPH3*, Linda Wu, PhD3*, Wasiulla Khan, PhD3*, Zaina P. Qureshi, PhD, MS, MPH3* and Moshe Yair Levy, MD4

1Hematology, Atrium Health Levine Cancer Institute, Charlotte, NC
2Janssen Scientific Affairs, LLC, Titusville, NJ
3Janssen Scientific Affairs, LLC, Horsham, PA
4Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX

Agrima Mian, MBBS, MD1, Wei Wei, MSc2*, Rajshekhar Chakraborty, MBBS3, Jean C. Yi, PhD4*, Jaime M. Preussler, MS5, Brian T. Hill, MD, PhD6, Jan Cerny, MD, PhD7, Abhinav Deol, MD8, Theresa E. Hahn, PhD9, Shahrukh K. Hashmi, MD, MPH10, Samantha Jaglowski, MD, MPH11, Heather S. L. Jim, PhD12*, Nandita Khera, MD, MPH13, Alison W. Loren, MD14, Joseph P. McGuirk, DO15, Bipin N. Savani, MD16, Patrick Stiff, MD17, Joseph P. Uberti, M.D., Ph.D.18, Victoria Whalen, B.S.19*, John R. Wingard, MD20, Jana Reynolds, MD21, Shernan G Holtan, MD22, William A. Wood, MD, MPH23, K. Scott Baker, MD, MS24, Karen L. Syrjala, PhD25*, Betty K. Hamilton, MD6 and Navneet S. Majhail, MD26

1Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
3Hematology and Oncology, Columbia University Medical Center, New York, NY
4Biobehavioral Sciences Department, Fred Hutchinson Cancer Research Center, Seattle, WA
5National Marrow Donor Program/Be The Match, Minneapolis, MN
6Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7University of Massachusetts Medical School, Worcester, MA
8Department of Oncology, Wayne State University/ Karmanos Cancer Institute, Detroit, MI
9Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
10Division of Hematology, Mayo Clinic, Rochester, MN
11Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH
12Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL
13Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
14Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
15Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
16Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
17Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL
18Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
19Section of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE
20Department of Medicine/Division of Hematology Oncology, University of Florida, Gainesville, FL
21Baylor University Medical Center, Dallas, TX
22University of Minnesota, Minneapolis, MN
23Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
24Fred Hutchinson Cancer Research Ctr., Seattle, WA
25Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
26Sarah Cannon, Nashville, TN

Tycel Phillips, MD1*, Pieternella Lugtenburg, MD, PhD2, Anupama Kalsekar, MS3*, Alex Mutebi, PhD3*, Anthony Wang, PhD, MPH4*, Julie Blaedel, MD3*, Katherine Kosa, MPH5*, Susan Martin, MPH5*, Mariana Sacchi, MD3* and Catherine Thieblemont, MD, PhD6

1University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
2Department of Hematology, On behalf of the HOVON lymphoma working group, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
3Genmab, Princeton, NJ
4AbbVie, Inc., North Chicago, IL
5RTI Health Solutions, Ann Arbor, MI
6APHP, Hôpital Saint-Louis, Hemato-Oncology, Paris, France; Diderot University, Sorbonne Paris-Cité, Paris, France

Carolyn Owen, MD1, Neil Chua, MD2*, Devon Boyne3,4*, Ofodile Joe-Uzuegbu4,5*, Huma Shakir3,4*, Priyanka Gonga3,4*, Darren Brenner3,4,6*, Julia Elia-Pacitti7*, Emmanuel Ewara7* and Winson Y Cheung, MD MPH3,4*

1Departments of Medicine and Oncology, University of Calgary, Calgary, AB, Canada
2Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
3Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada
4Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
5Oncology Outcomes Research Initiative,, University of Calgary, Calgary, AB, Canada
6Department of Community Health Science, University of Calgary, Calgary, AB, Canada
7Janssen Inc., Toronto, ON, Canada

Kara I. Cicero, MD, MPH1, Alfred I. Neugut, MD, PhD2*, Andrew H. Doyle3*, Divaya Bhutani, MD4, Amer Assal, MD5, Ran Reshef, MD, MSc6, Markus Y. Mapara, MD7, Suzanne Lentzsch, MD, PhD8 and Rajshekhar Chakraborty, MBBS9

1New York Presbyterian, Columbia University Medical Center, New York, NY
2Columbia University Medical Center, New York
3Columbia University, New York, NY
4Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
5Blood and Marrow Transplantation Program, Columbia University Medical Center, New York, NY
6Blood and Marrow Transplantation Program, Columbia University, New York, NY
7Department of Medicine, Division of Hematology/Oncology, Columbia University College of Physcians and Surgeons, New York, NY
8Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY
9Hematology and Oncology, Columbia University Medical Center, New York, NY

Anca Prica, MD, MSc1, Tiana Coley, BS1*, Rachel Aitken, MSc1*, Abi Vijenthira, MD1, Manjula Maganti, MSc2*, Samantha J Mayo, PhD, RN3*, Christine I. Chen, MD1, John Kuruvilla, MD1, Michael Crump, MD1, Sita Bhella, M.D., MSc1*, Robert Kridel, MD1, Vishal Kukreti, MD, FRCP, MSc1, Chloe Yang, MD1* and Shabbir Alibhai, MD, MSc, FRCP4*

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
2Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
4Department of Medicine, University Health Network, Toronto, ON, Canada

Blake Foxworthy, MD1*, Elizabeth C Davis, MSPH2*, Ana C. Xavier, MD1, Julienne Brackett, MD, MS3, David Dickens, MD4*, Alissa R. Kahn, MD5*, Isaac Martinez6*, Archana Sharma, DO7*, Carla Schwalm, MD8*, Jessica M. Foley, MD9, Jennifer J. Wilkes, MD, MSCE10, Smita Bhatia, MD, MPH6, Jennifer M Levine, MD, MS11*, Emily Johnston, MD, MS6 and Julie A. Wolfson, MD, MS12

1University of Alabama at Birmingham, Birmingham, AL
2Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL
3TX Children's Children Cancer & Hematology Centers, Houston, TX
4Division of Pediatric Hematology and Oncology, University of Iowa, Iowa City, IA
5St. Joseph's Health, Paterson, NJ
6Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
7Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
8Bronson Health Group, Kalamazoo, MI
9Helen Devos Children's Hospital, Grand Rapids, MI
10Seattle Children's Hospital, Seattle, WA
11Weill Cornell Medical College, New York, NY
12Pediatric Hematology-Oncology, Institute for Cancer Outcomes and Survivorship, University of Alabama Birmingham, Birmingham, AL

Camila Alves da Silva, MD1*, Juliana Pereira, MD, PhD2, Eduardo M Rego, MD, PhD3,4, Vanderson Rocha, MD, PhD4* and Wellington F Silva Jr., MD PhD4

1Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
2Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SAO PAULO, Brazil
3Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology, Department of Hematology (LIM-31), University of Sao Paulo, São Paulo, Brazil
4Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil

Max J. Gordon, MD1, Zhigang Duan, MS2*, Hui Zhao3*, Loretta J. Nastoupil, MD4, Alessandra Ferrajoli5, Alexey V Danilov, MD6 and Sharon Giordano, MD7*

1University of Texas MD Anderson, Houston
2University of Texas MD Anderson, Texas, TX
3University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6City of Hope, La Canada Flintridge, CA
7University of Texas MD Anderson, Houston, TX

Amaris K. Balitsky, MD, MSc, FRCPC1,2, Gregory R Pond, PhD, PStat2*, Graeme Fraser, MD, MSc, FRCPC1,2, Tom Kouroukis, MD, MSc , FRCPC1,2 and Stephen Ronan Foley, MD, FRCPC1,2

1Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada
2Department of Oncology, McMaster University, Hamilton, ON, Canada

Samer Al Hadidi, MD, MSc1, Aniko Szabo, PhD2*, Jean Esselmann3*, Lindsay Hammons, MD4, Munawwar Hussain, MD5*, Yetunde Ogunsesan, MD5*, Nishanth Thalambedu, MD6*, Fatima Khan6*, Jaskirat Sethi, MD5*, Abhishek Janardan3*, Sabarinath Radhakrishnan7*, Sharmilan Thanendrarajan, MD1, Carolina Schinke1, Binod Dhakal, MBBS8, Siegfried Janz9, Saurabh Chhabra, MD, MS10, Anita D'Souza, MD, MS11, Maurizio Zangari, MD1, Frits van Rhee5 and Meera Mohan, MD12

1Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
2Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
3Bone Marrow Transplant Service, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI
4Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
5Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
6Myeloma Center, Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
7Medical college of Wisconsin, Milwaukee, WI
8Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
9Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
10Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
11Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
12Medical College of Wisconsin, Milwaukee, WI

Sikander Ailawadhi1, Arliene Ravelo, MPH2*, Carmen Ng, PhD2*, Bonny Shah, MPH3*, Rongrong Wang, MPH2*, Katherine Eakle, PharmD2* and Juliana Biondo, MD2

1Mayo Clinic, Jacksonville, FL
2Genentech, Inc., South San Francisco, CA
3Genesis Research, Hoboken, NJ

Chattip Prueksapraopong, MD1,2, Trevor Hirata3*, Lauryn Liao3*, Kyle Ishikawa4*, John J. Chen4*, Wade Kyono, MD4,5*, Darryl W. Glaser, MD4,5*, Randal Wada, MD4,5*, Rodolfo Bégué, MD4,6*, Brian T. Fisher, DO, MSCE7*, Lena E. Winestone, MD8, Kelley C. Okimoto, MD4,5* and Stephanie Si Lim, MD3,4,5

1Pediatric Residency Program, University of Hawai’i, John A. Burns School of Medicine, Honolulu, HI
2Kapi’olani Medical Center for Women and Children, Honolulu, HI
3University of Hawai’i Cancer Center, Honolulu, HI
4University of Hawai’i, John A. Burns School of Medicine, Honolulu, HI
5Division of Hematology Oncology, Kapi’olani Medical Center for Women and Children, Honolulu, HI
6Division of Infectious Diseases, Kapi’olani Medical Center for Women and Children, Honolulu, HI
7Division of Infectious Disease, Children's Hospital of Philadelphia, Philadelphia, PA
8Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA

Sophia C Cornew, MBA1*, Anthony B Cardillo2*, Louis J DeGennaro, PhD3, Paul A Fields, PhD4*, Lore M Gruenbaum, PhD3, Hana Littleford, PhD2*, Richard L Martin, PhD2*, Gwen L Nichols, MD3, Amanda C Nottke, PhD2*, Conner M O'Brien, BS2*, Sneha T Reddy, MD3*, Rhonda Rosenbaum, MS2*, Larry A Saltzman, MD3*, Catherine Sanders, PhD4*, Jun Xu, PhD3 and Lee M Greenberger, PhD3

11400 16th Street, Invitae, San Francisco, CA
2Invitae, San Francisco, CA
3The Leukemia & Lymphoma Society, Rye Brook, NY
4Adaptive Biotechnologies, Seattle, WA

Alexander Didier1*, Ying Ning, MD1*, Andrew Campbell, MD1* and Danae M Hamouda, MD2

1Department of Medicine, The University of Toledo College of Medicine and Life Sciences, Toledo, OH
2University of Toledo/University of Toledo Medical Center & Dana Cancer Center, toledo, OH

Gayathri Ravi, MD1, Smith Giri, MD, MHS2, Susan Bal, MD3, Kelly N. Godby, MD4*, Vishnu V.B. Reddy, MD5, Donna Salzman, MD6, Omar Alkharabsheh, MBBS7, Scott A. McDaniel, MD8*, Melissa Sentell9* and Luciano J. Megala Costa, MD, PhD10

1Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
2Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
3O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
4Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Hospital, Birmingham, AL
5Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
6University of Alabama at Birmingham, Birmingham, AL
7Mitchell Cancer Institute, University of South Alabama, Mobile, AL
8Alabama Oncology Hematology Associates, Montgomery, AL
9University of Alabama, Birmingham, AL
10University of Alabama at Birmingham Hospital, Vestavia, AL

Ana Vagos Mata, M.D.1,2*, Daniel Gomes, M.D.3*, Pedro Mendonça, Medical Student4*, Pedro De Vasconcelos, M.D.5*, Daniela Alves, MD6,7*, João Santos Silva, M.D.3*, João Ribeiro, M.D.3*, João F Lacerda, M.D., PhD8,9 and João Raposo, M.D.8*

1Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal, Lisbon, Portugal
2Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, Lisboa, Portugal
3Serviço de Medicina Intensiva, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, Lisbon, Portugal
4Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, Lisbon, Portugal
5Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, Lisbon, Portugal
6Department of Hematology and Marrow Transplantation, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte, Lisbon, Portugal
7Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
8Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
9Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Jenna L Tate, MSc1*, Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD2, Kathryn Riley3*, Lydia Skertchly4*, Thea Chandler, MD4*, Frances Seymour5* and Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath6*

1Haematology, St James's University Hospital, Leeds, United Kingdom
2Leeds Teaching Hospitals NHS Trust, Leeds, ENG, United Kingdom
3Department of Haematology, St James University Hospital, Leeds, United Kingdom
4St James's University Hospital, Leeds, United Kingdom
5Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
6Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Allison Winter, MD1, Nicholas Liu, PharmD2*, Andy Surinach, MPH3*, Michelle A. Fanale, MD2, Kristina S. Yu, PhD, MPH, RPh2* and Mayur Narkhede, MBBS4

1Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Seagen Inc., Bothell, WA
3Genesis Research, Hoboken, NJ
4University of Alabama-Birmingham, Birmingham, AL

Tariqa Ackbarali, PhD1*, Susan M. O'Brien2, Anthony R. Mato, MD, MSCE3 and Matthew S. Davids, MD4

1PlatformQ Health, Lake Worth, FL
2UCI Cancer Center, Orange, CA
3CLL Program, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
4Department of Medical Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA

Mehdi Hamadani, MD1, Laura Liao2*, Lauren Wilson, MPH3*, Amanda Howarth, MPH3*, Carlos Flores, MPH3* and Lei Chen, MD, PhD2*

1Department of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
2ADC Therapeutics America, Inc., New Providence, NJ
3Genesis Research, Hoboken, NJ

Akiva Diamond, MD1, Wyatt P. Bensken, PhD2*, Long Vu, MS2*, Siran M. Koroukian, PhD2* and Paolo F. Caimi, MD3,4

1Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke's Medical Center, Houston, TX
2Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH
3Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
4Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Neda Alrawashdh, PharmD1* and Ivo Abraham, PhD, RN2

1Center for Health Outcomes and Pharmacoeconomic Research, university of arizona, TUCSON, AZ
2Center for Health Outcomes and PharmacoEconomic Research, University of Arizona - College of Pharmacy, Tucson, AZ

Catherine Thieblemont, MD, PhD1, Qiufei Ma2*, Christian Hampp2*, James Harnett2*, Rachel E. Sobel2*, Jessica J. Jalbert, PhD2*, Ruben G.W. Quek2*, Wenhui Wei, PhD2*, Ning Wu2*, Vera Mastey2*, Joy Wang2*, Anit Bajwa2*, Benedikt Maissenhaelter3*, Chantal van Gils4*, Shivani Aggarwal5*, Aafia Chaudhry, MD, MBA, MS2*, Hesham Mohamed, MD2*, Srikanth R. Ambati, MBBS, MD2*, Emmanuel Bachy, MD, PhD6* and Gandhi Laurent Damaj, MD, PhD7*

1Université de Paris, Assistance Publique – Hôpitaux de Paris, Hopital Saint-Louis, Hemato-Oncologie, Paris, France
2Regeneron Pharmaceuticals, Inc., Tarrytown, NY
3IQVIA, Munich, Germany
4IQVIA, Rotterdam, Netherlands
5IQVIA, Los Angeles, CA
6Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
7Institut d'Hematologie de Basse-Normandie, CHU Cote de Nacre, Université de Normandie, Caen, France

Avi Leader, MD1,2*, Hila Magen, MD1,3*, Irina Amitai, MD4,5*, Antoine Pironet, PhD6*, Eric Tousset, M.Sc.6*, Alon Rozental, MD1,7*, Sabina De Geest, PhD RN8,9*, Iuliana Vaxman, MD, BA1,2*, Pia Raanani, MD1,7 and Arnon Nagler, MD1,10

1Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
3Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel
4Division of Hematology, Chaim Sheba Medical Center, Ramat-Gan, Israel
5Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
6AARDEX Group, Liège, Belgium
7Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
8Institute of Nursing Science, Department Public Health, University of Basel, Basel, BS, CHE
9Academic Centre of Nursing and Midwifery, Department Public Health and Primary Care, KU Leuven, Leuven, Belgium
10Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel

Fieke W Hoff, MD, PhD1, Yazan F. Madanat, MD2, Heather Lapidus Glassner3* and Beth Schneider3*

1UT Southwestern Medical Center, Dallas, TX
2Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
3My Health Team, San Francisco

Sujitha Ketineni, MD1, Calvin Abro, MD1, Xianming Zhu, MBBS, MPH2*, Vivek Prakash, MS, MBA3*, Sarah S. Makhani, MD4, Kathy Robinson, PhD1*, Aliyah Hashmi, BS5*, Bhavya Vemuri, MD6*, Mohammad Hussain, MD1* and Ruchika Goel, MD, MPH1,7

1Division of Hematology/Oncology, Simmons Cancer Institute, SIU School of Medicine, Springfield, IL
2Johns Hopkins Medicine, Baltimore, MD
3Center for Clinical Research, SIU School of Medicine, Springfield, IL
4Department of Medicine, NYU Langone Health, New York City, NY
5SIU School of Medicine, Springfield, IL
6St. Mary's Hospital, Waterbury, CT
7Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD

Polina Bellman, MD1, Wei Cui, MD2,3*, Zahra Mahmoudjafari, PhD2,4*, Shebli Atrash, MD2,5, Barry Paul, MD, MS2,6, Hamza Hashmi, MD2,7, Rajesh Banderudrappagari8*, Leyla O. Shune, MD9,10, Al-Ola Abdallah, MD10,11 and Nausheen Ahmed, MD2,12

1University of Kansas Medical Center, Kansas city, KS
2US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, KS
3University of Kansas Medical Center, Kansas City, KS
4Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
5Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
6Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC
7Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
8CoxHealth, Springfield, MO
9The University of Kansas Medical Center, Kansas City, KS
10US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS
11Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
12Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS

Calvin Abro, MD1, Sujitha Ketineni, MD1, Sarah S. Makhani, MD2, Xianming Zhu, MBBS, MPH3*, Bhavya Vemuri, MD4*, Vivek Prakash, MS, MBA5*, Kathy Robinson, PhD1*, Mohammad Hussain, MD1* and Ruchika Goel, MD, MPH1,6

1Division of Hematology/Oncology, Simmons Cancer Institute, SIU School of Medicine, Springfield, IL
2Department of Medicine, NYU Langone Health, New York City, NY
3Johns Hopkins Medicine, Baltimore, MD
4St. Mary's Hospital, Waterbury, CT
5Center for Clinical Research, SIU School of Medicine, Springfield, IL
6Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD

Megan C Braunlin, MPH1*, Tingting Gong, MS2*, Rebecca Payne3*, Chuanyu Kou, MS2*, Babatunde Adedokun, MD, PhD1*, Kelly Velasco, PharmD4* and Shuling Li, PhD2

1Center for Observational Research, Amgen Inc., Thousand Oaks, CA
2Chronic Disease Research Group, Minneapolis, MN
3SimulStat, Solana Beach, CA
4Medical Affairs, Amgen Inc., Thousand Oaks, CA

Alexander Russell-Smith, MSc1*, Louise Murphy, PhD2*, Amy Nguyen, PhD2*, Feng Cao, PhD, MS2*, Shiqiang Li, MS2* and Richa Shah, PharmD3

1Pfizer R&D Ltd, Sandwich, NY, United Kingdom
2Optum, Eden Prairie, MN
3Pfizer Inc., New York

Rashmi Suresh Yawalkar, MBBS, MD1*, Mobin Paul, MBBS, MD, DM2*, Reshmy G S, M.Sc Medical biochemistry3*, Mrudula E.V., M.Sc Medical biochemistry4*, Rema Ganapathy, MBBS DNB5*, Manoj Unni, MD DM6*, Chitresh Yadav, MBBS, MD7*, Shreya Gopal Agrawal, MBBS, MD8*, Sandeep abhijit Pattanik, MBBS, MD9*, Gohul Gopi Jalajakumari,, MBBS, MD9*, Aswathy Ashok Beenakumary, Clinical pharmacist9*, Anjaly s Nair, MSc Biostatistics10*, Ullas Mony, PhD11* and Neeraj Sidharthan, MD, MBBS, DM, DNB12

1Clinical haematology, AIMS hospital, kochi, India
2Clinical Haematology and Haemato-oncology, Rajagiri Hospital, Aluva, India
3Biochemistry, Amrita institute of Medical sciences, Kochi, India
4Biochemistry, Amrita institute of medical sciences, Kochi, AL, IND
5Department of Clinical Haematology, Amrita Institute of Medical Sciences, Kochi, India
6Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences, Kochi, India
7Clinical haematology, Amrita institute of Medical sciences, kochi, India
8Clinical Haematology, Amrita institute of Medical sciences, Kochi, India
9Clinical haematology, Amrita institute of Medical sciences, Kochi, India
10Department of Biostatistics, Amrita institute of Medical sciences, Kochi, India
11Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College and Hospitals, Saveetha institute of medical and technical sciences, Chennai, Chennai, India
12Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences , Amrita University, Kochi, Kerala, India

Oreofe O. Odejide, MD, MPH1, Tamryn F. Gray, RN, PhD, MPH1*, Tsotso Ablorh, MA2*, Miryam Yusufov, PhD1*, Gregory A. Abel, MD, MPH1 and Lizabeth Roemer, PhD2*

1Dana-Farber Cancer Institute, Boston, MA
2Department of Psychology, University of Massachusetts, Boston, MA

John L Vaughn, MD, MS1 and Narendranath Epperla, MD, MS2

1Yale New Haven Health, New Haven, CT
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Joshua Richter, MD1, Sikander Ailawadhi2, Hans C. Lee, MD3, James W. Hardin, PhD4*, Howard R. Terebelo, DO5, Rafat Abonour, MD6, Lynne I. Wagner, PhD7*, Brian G.M. Durie, MD8, James L. Omel, MD9*, Mohit Narang, MD10*, Kathleen Toomey, MD11*, Robert M. Rifkin, MD12, Cristina J. Gasparetto, MD13, Edward Yu, ScD14*, Jasmeet Anand, PharmD14*, Liang Liu, MS14*, Ying-Ming Jou, PhD14* and Sundar Jagannath1

1Mount Sinai Hospital, New York City, NY
2Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
3The University of Texas M.D. Anderson Cancer Center, Houston, TX
4University of South Carolina, Columbia, SC
5Providence Cancer Institute, Southfield, MI
6Indiana University, Indianapolis, IN
7Wake Forest School of Medicine, Winston Salem, NC
8Cedars-Sinai Medical Center, Los Angeles, CA
9Myeloma Research Advocate/Advisor, Grand Island, NE
10US Oncology Research, Columbia, MD
11Steeplechase Cancer Center, Somerville, NJ
12Rocky Mountain Cancer Center, Denver, CO
13Duke University Medical Center, Durham, NC
14Bristol Myers Squibb, Princeton, NJ

Mohammad S Ebraheem, MD1, Eli Muchtar, MD1*, Shaji K Kumar, MD1, Angela Dispenzieri, MD1, Francis K. Buadi, MB1, David Dingli, MD, PhD1, Joselle Cook, MBBS1, Martha Q. Lacy, MD1, Suzanne R. Hayman, MD1, Prashant Kapoor, MD1, Nelson Leung, MD1, Rahma M Warsame, MD1, Taxiarchis Kourelis, MD1, Moritz Binder, MD, MPH1, Ronald Go, MD1, Amie Fonder, PA-C1*, Yi L. Hwa, NP1, Miriam A. Hobbs, APRN, CNP, DNP1*, Wilson I. Gonsalves, MD1, S. Vincent Rajkumar, MD1, Robert A. Kyle, MD2 and Morie A Gertz, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN

Alberto Lázaro García, MD1, Marta González Rodríguez, MD2*, Edwin Uriel Suárez Merchán, MD1*, Gonzalo Castellanos Arias, MD1*, Alicia de las Heras Moreno, MD1*, María Pilar Llamas Sillero, MD, PhD1*, Eduardo García Romo, MD, PhD3*, Antonio Noguera Tejedor, MD, PhD3*, Laura Solán Blanco, MD, PhD1*, Antonio Herrero4* and Juan Manuel Alonso Dominguez, MD, PhD1*

1Department of Hematology, Fundación Jiménez Díaz University Hospital, Madrid, Spain
2Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain
3Department of Palliative Care, Fundación Jiménez Díaz University Hospital, Madrid, Spain
4Information and Communication Technology (ICT) Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain

Nick York1*, Deborah Baker1*, Kathryn Huntley1*, Michael Rynne1*, Nicole Schroeter1*, Jennie Bradley2*, Anna Schuh, MD, PhD, FRCP, FRCPath3, Nicole Lamanna, MD4 and Alina S. Gerrie, MD, MPH, FRCPC5

1CLL Advocates Network, Bern, Switzerland
2IQVIA, Chesterfield, ENG, United Kingdom
3Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
4Columbia University, Herbert Irving Comprehensive Cancer Center, New York
5BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada

Nishanth Thalambedu, MD1*, Kuldeepsinh Atodaria, MBBS2 and Christian Joseph Fidler, MD3*

1Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
2Jefferson Health - Abington, Willow Grove, PA
3Hematology and Medical Oncology, Jefferson Health - Abington, Abington, PA

Kevin Tang, MD1,2, Heidi M Krause, BS2*, Nikhil Patel, MD2*, Grace Hwang, PharmD3*, Jason Lu, MD2*, Martha P. Mims, MD, PhD4,5,6, Mark M. Udden, MD4,5,6, Courtney Nicole Miller-Chism, MD4,5,6, Gustavo Rivero, MD4,5,6 and Purnima Sravanti Teegavarapu, MD4,5,6

1Center for Translational Research on Inflammatory Disease (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX
2Department of Medicine, Baylor College of Medicine, Houston, TX
3Department of Pharmacy, Baylor St.Luke's Medical Center, Houston, TX
4Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX
5Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX
6Department of Hematology/Oncology, Baylor St Luke's Medical Center, Houston, TX

Oluwasegun Akinyemi, MD1,2*, Faith O Abodunrin, MD3, Oluwatayo Adeoye, MD4*, Akinwale Akingbule, MD, MS5*, Olanrewaju Oni, MD, MS6*, Bolarinwa Akinwumi, MD, MS7*, Ademola Ojo, MD8*, Oluwaseun B Ogunbona, MBBS PhD9* and Peter Silberstein, MD10*

1The Clive O. Callender Outcomes Research Center, Howard University College of Medicine, Macomb, IL
2Department of Health Policy and Management, University of Maryland School of Public Health, College Park, MD
3Department of Internal Medicine, Creighton University, OMAHA, NE
4Department of Internal Medicine, St Elizabeth's Medical Center, Boston, MA
5Department of Public Health, Ozark valley medical Clinic,, Branson, MO
6Department of Pathology, Howard University College of Medicine, Washington, DC
7Western Illinois University, Macomb, IL
8Department of Internal Medicine, Howard University College of Medicine, Washington, DC
9Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX
10Department of Medicine, Creighton University Medical Center, Omaha, NE

Isabel González-gascón-y-Marín, MD, PhD1*, Sara Martínez-Flores, MD2*, Elena Landete, MD1*, Elena Baeza-Monedero, MD2*, María Ángeles Foncillas, MD1*, Paula Fernández-Montalbán, MD2*, Carolina Cecilia Muñoz-Novas, MD1*, Maria Stefania Infante, MD1*, Karen Marín-Mori, MD1*, Juan Churruca Sarasqueta, MD1*, Laura Sánchez-Paz, MD1*, Victoria Ramos-de-Ascanio, MD1*, Fátima Brañas, MD, PhD2* and José Ángel Hernández-Rivas, MD, PhD1,3*

1Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
2Geriatrics Department, Hospital Universitario Infanta Leonor, Madrid, Spain
3Medicine Department, Universidad Complutense de Madrid, Madrid, Spain

*signifies non-member of ASH